[Immunity to measles, mumps and rubella in children vaccinated with triple viral vaccine].
OBJECTIVE
To check up on measles-mumps-rubella immunity in children vaccinated with MMR vaccine.


METHODS
A descriptive cross-sectional study trough seroepidemiological survey.


METHODS
Oliver-Miralbueno Health Centre, Zaragoza.


METHODS
92 healthy children of 5, 7 and 9 years of age who went for clinical preventive services. All of them vaccinated with MMR at the age of 15 to 18 months. None of them had suffered from measles, mumps or rubella.


RESULTS
1) The percentage of seronegative children (title less than 1:8) was: 9.8% for measles, 8.7% for rubella, and 27.2% for mumps. 2) As to the time differences among seropositive and seronegative children.


CONCLUSIONS
The study reveals that there is a high percentage of MMR vaccinated children showing minimal or undetectable levels of antibodies.
Pisón Garcés
F J
FJ
Centro de Salud Oliver-Miralbueno, Zaragoza.
Galbe Sánchez-Ventura
J
J
Arcauz Eguren
P
P
Aguirre y Dabán
C
C
Mengual Gil
J
J
Larrad Mur
L
L
D000367:Age Factors; D000914:Antibodies, Viral / Q000032:analysis*; D000917:Antibody Formation; D002648:Child; D002675:Child, Preschool; D003430:Cross-Sectional Studies; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D007223:Infant; D008457:Measles / Q000276:immunology*; D008458:Measles Vaccine / Q000008:administration & dosage* / Q000276:immunology; D009107:Mumps / Q000276:immunology*; D009108:Mumps Vaccine / Q000008:administration & dosage* / Q000276:immunology; D012409:Rubella / Q000276:immunology*; D012411:Rubella Vaccine / Q000008:administration & dosage* / Q000276:immunology; D013997:Time Factors; D014611:Vaccination
D000914:Antibodies, Viral; D008458:Measles Vaccine; D009108:Mumps Vaccine; D012411:Rubella Vaccine